141 of 291 patients completed the questionnaire, corresponding to a participation rate of 48%. After exclusion of the patients that had passed away at the time of the interview, the participation rate amounts to 59%. Figure 1 depicts the participation in the study with inclusion of the reasons for non-participation.
The majority of patients suffered from ovarian cancer (64%, n = 90). 23% (n = 32) were suffering from endometrial cancer, 9% (n = 13) from cervical cancer and further 4% (n = 6) from vulvar cancer.